204
Participants
Start Date
July 31, 2013
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
R348 Ophthalmic Solution, 0.2%
R348 Ophthalmic Solution, 0.2% 1 drop per eye twice a day for 12 weeks.
R348 Ophthalmic Solution, 0.5%
R348 Ophthalmic Solution, 0.5% 1 drop per eye twice a day for 12 weeks.
Placebo
Placebo Ophthalmic Solution 1 drop per eye twice a day for 12 weeks.
Cornerstone Eyecare, High Point
Mundorf Eye Center, Charlotte
Charlotte Eye Ear Nose and Throat Associates, PA, Charlotte
Glaucoma Consultants and Center for Eye Research, Mt. Pleasant
Coastal Research Associates, Roswell
Clayton Eye Center, Morrow
International Research Center, Brandon
East Florida Eye Institute, Stuart
Chattanooga Eye Institute, Chattanooga
Koffler Vision Group, Lebanon
Taustine Eye Center, Louisville
Abrams Eye Center, Cleveland
Chicago Cornea Consultants, Hoffman Estates
Chicago Research Center, Chicago
Comprehensive Eye Care, Ltd/Vision Research Institute, LLC, Washington
Eye Clinics of South Texas, San Antonio
Sall Research Medical Center, Artesia
North Bay Eye, Petaluma
Martel Medical Eye Group, Rancho Cardova
Specialty Eye Care, Parker
Lead Sponsor
Rigel Pharmaceuticals
INDUSTRY